About Us

Many years of research, led by Dr. Jack Kessler, have resulted in a major breakthrough in iodine chemistry. Dr. Kessler has developed a unique and stable formulation of free molecular iodine (I₂) that enables it to be highly concentrated as an ingredient in a variety of mediums. This higher concentration of free iodine increases the native virucidal activity of I₂ to kill bacteria, viruses and fungi. The antimicrobial activity is proportional to the concentration of the free iodine (I₂) released⁵.

When applied to the skin, the free molecular iodine (I₂) is absorbed directly into the dermis. It cannot be washed away⁴.

Our Leadership Team

Jack Kessler PhD - I2PURE Chief Scientist

Dr. Jack Kessler - Chief Science Officer

The I2PURE formulations come from a long line of revolutionary inventions by Dr. Jack Kessler. Dr. Kessler’s academic journey began at Steven’s Institute of Technology where he obtained his Bachelor of Science. He later went on achieve his Ph.D. in Chemistry from the State University of New York, Syracuse.

Dr. Jack Kessler has worked as Senior Scientist, New Technology Evaluation at Hoffman-LaRoche, a Swiss multinational healthcare company. He later went on to work as Senior Principal Systems Engineer at Elbit Systems of America. He is a member of the founding team of Symbollon Pharmaceuticals, Iotech International and I2PURE, all three of which are focused on the development and commercialization of proprietary drugs based on molecular iodine technology.

He has led formulation teams responsible for the development of several iodine-based products including the Violet tablet, ioRinse line of oral care products and the initial generation (powder) of the Iodozyme teat dip product marketed by DeLaval. He has also published basic and applied research on iodine formulations and the biochemistry of iodine/thyroid hormones.

Dr. Kessler’s list of inventions includes a molecular iodine-based solid oral dosage for mammary dysplasia and methods, systems, and devices to identify microorganisms in culture samples. Dr. Kessler has dedicated more than 25 years to the development of applicative areas of iodine-based formulations, bio-analytical assays, and in vitro diagnostic (IVD) medical devices.

Dr. Jack Kessler’s patents have been filed for approval at the United States Patent and Trademark Office (USPTO). His patent listings include applications pending approval as well as patents already granted by the USPTO.

Dr. Khizer Khaderi - I2PURE Chief Medical Officer

Dr. Khizer Khaderi - Chief Medical Officer

We would like to introduce I2PURE’s Chief Medical Officer, the world-renown MD and visionary, Dr. Khizer Khaderi. He will help propel forward, I2PURE’s novel approach to the fight against destructive pathogens impacting communities across the globe.

Dr. Khaderi is Director/Founder of the Stanford Human Perception Laboratory (HPL) and the Stanford Performance Vision Center (PVC), Clinical Associate Professor at Stanford University and faculty at the Stanford Institute for Human-Centered AI.

He is a renowned Neuro-Ophthalmic surgeon, technologist and futurist. Dr. Khaderi is CEO of Vizzario Inc, a Perceptual AI company, spun out from HPL.

He has extensive domain expertise in AI, VR/AR/MxR, wearables, applied neuroscience, human factors, human-machine interaction and AI. His experience across industry sectors include consumer electronics, gaming, retail, life science, sports/Esports health care, Pharma, e-commerce, to name a few. He has developed novel technologies in these areas and generated multiple invention patents.

Selected as a “40 under 40”, he contributed to President Obama’s Council of Advisors on Science and Technology regarding vision technology and the aging population. He also advises multiple companies, venture firms and organizations including the Global Esports Federation, Magic Leap, Riot Games, Intel, Activision, Unity, Epic Games, Google, FB, Microsoft, Apple, NBA, Aerie Pharma, the World Health Organization and the World Bank.